Page 19 - Syntax Advisors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Meiji Yasuda Asset Management Co Ltd. increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 15.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,882 shares of the healthcare conglomerate’s stock after acquiring an additional […]

Visionary Wealth Advisors raised its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 5.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 60,025 shares of the company’s stock after purchasing an additional 2,840 shares during the period. Visionary […]

Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report)‘s stock had its “reduce” rating reaffirmed by analysts at HSBC in a research note issued to investors on Tuesday, MarketBeat Ratings reports. They presently have a $20.00 price target on the pharmacy operator’s stock, down from their previous price target of $27.00. HSBC’s price objective would indicate […]

Visionary Wealth Advisors raised its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 5.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 60,025 shares of the company’s stock after purchasing an additional 2,840 shares during the period. Visionary […]

Alan B Lancz & Associates Inc. trimmed its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 4.7% during the third quarter, Holdings Channel.com reports. The fund owned 6,167 shares of the company’s stock after selling 307 shares during the period. AbbVie accounts for about 1.0% of Alan B Lancz & Associates Inc.’s investment portfolio, […]